Corticosteroids: A boon or bane for COVID-19 patients?
Several drugs and antibodies have been repurposed to treat COVID-19. Since the outcome
of the drugs and antibodies clinical studies have been mostly inconclusive or with lesser …
of the drugs and antibodies clinical studies have been mostly inconclusive or with lesser …
[HTML][HTML] Corticosteroids: A boon or bane for COVID-19 patients?
S Sen, B Singh, G Biswas - Steroids, 2022 - ncbi.nlm.nih.gov
Several drugs and antibodies have been repurposed to treat COVID-19. Since the outcome
of the drugs and antibodies clinical studies have been mostly inconclusive or with lesser …
of the drugs and antibodies clinical studies have been mostly inconclusive or with lesser …
Corticosteroids: a boon or bane for COVID-19 patients?
S Sen, B Singh, G Biswas - 2022 - cabidigitallibrary.org
Several drugs and antibodies have been repurposed to treat COVID-19. Since the outcome
of the drugs and antibodies clinical studies have been mostly inconclusive or with lesser …
of the drugs and antibodies clinical studies have been mostly inconclusive or with lesser …
Corticosteroids: A boon or bane for COVID-19 patients?
S Sen, B Singh, G Biswas - Steroids, 2022 - europepmc.org
Several drugs and antibodies have been repurposed to treat COVID-19. Since the outcome
of the drugs and antibodies clinical studies have been mostly inconclusive or with lesser …
of the drugs and antibodies clinical studies have been mostly inconclusive or with lesser …
Corticosteroids: A boon or bane for COVID-19 patients?
S Sen, B Singh, G Biswas - Steroids, 2022 - pubmed.ncbi.nlm.nih.gov
Several drugs and antibodies have been repurposed to treat COVID-19. Since the outcome
of the drugs and antibodies clinical studies have been mostly inconclusive or with lesser …
of the drugs and antibodies clinical studies have been mostly inconclusive or with lesser …
Corticosteroids: A Boon or Bane for COVID-19 Patients?
S Sen, B Singh, G Biswas - Steroids, 2022 - europepmc.org
Several drugs and antibodies have been repurposed to treat COVID-19. Since the outcome
of the drugs and antibodies clinical studies have been mostly inconclusive or with lesser …
of the drugs and antibodies clinical studies have been mostly inconclusive or with lesser …